Immunoglobulins Market Size, Share, Industry Analysis 2023

According to Precision Business Insights (PBI), the latest report, the immunoglobulins market was valued at USD 14,782.7 million in 2022 and is expected to grow at a 6.2% CAGR from 2023 to 2029. The primary drivers of the expansion of the global immunoglobulins market include the increasing prevalence of autoimmune disorders and chronic immunodeficiency diseases. In addition, growing geriatric populations are expected to boost the growth of the immunoglobulins market.

View the detailed report description here https://www.precisionbusinessinsights.com/market-reports/immunoglobulin-market

The immunoglobulins market is segmented based on product, mode of delivery, application, and geography.

Based on the product, the market is segmented into the following:
• IgG
• IgA
• IgM
• IgE
• IgD

Based on the mode of delivery, the market is segmented into the following:
• Intravenous
• Subcutaneous

Based on the application, the market is segmented into the following:
• Hypogammaglobulinemia
• Chronic Inflammatory Demyelinating Polyneuropathy
• Immunodeficiency Disease
• Myasthenia Gravis
• Other Applications

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Based on the mode of delivery, the global Immunoglobulins market is segmented into intravenous mode of delivery, and subcutaneous mode of delivery. The intravenous mode of delivery segment is expected to account for a larger revenue share in the global immunoglobulins market. The increasing demand for intravenous route of immunoglobulins therapy along with certain advantages such as rapid exposure, minimal volume constraints are expected to drive the market growth in this segment over the forecast period. Furthermore, increasing strategic initiatives regarding intravenous immunoglobulins and increasing number of drug approvals in this segment is expected to boost the market growth in this segment.

North America Immunoglobulins Market
The North America immunoglobulins market is expected to increase over the forecast period due to the increasing healthcare expenditure along with the increasing consciousness about the products involved in the treatment of immunodeficiency disorders. In addition, increasing approvals of drugs by the regulatory authorities in this region is anticipated to propel the growth of immunoglobulins market at a significant rate in this region. For instance, in July 2021, the USFDA approved Octa pharma USA for Octa gram 10% immune globulin intravenous for the treatment of dermatomyositis. Furthermore, growing inclinations of clinicians in the immunodeficiency therapies is expected to fuel the market growth in this region over the forecast period.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.

The global Immunoglobulins market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In January 2022, the European Union expanded the indication for cutaquig by Octa pharma. It is a human immunoglobulin for subcutaneous administration for any type of secondary immunodeficiency who need immunoglobulin replacement therapy.

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=898286

Key players profiles in the Immunoglobulins Market report are Baxter International Inc., CSL Ltd., Octa pharma AG, Kedrion Biopharma Inc., Grifols S.A, Cygnus Technologies, Mabtech, ADMA Biologics, Inc, Option Care Enterprises, Inc., Momenta Pharmaceuticals, Coram LLC, GREEN Cross Corp.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.